Apoptosis-inducing factor (AIF) deficiency compromises oxidative phosphorylation. Harlequin mice, in which AIF is downregulated, develop a severe mitochondrial complex I (CI) deficiency, suggesting that Harlequin mice may represent a natural model of the most common oxidative phosphorylation disorders. However, the brain phenotype specifically involves the cerebellum, whereas human CI deficiencies often manifest as complex multifocal neuropathologies. To evaluate whether this model can be used as to study CI-deficient disorders, the whole brain of Harlequin mice was investigated during the course of the disease. Neurodegeneration was not restricted to the cerebellum but progressively affected thalamic, striatal, and cortical regions as well. Strong astroglial and microglial activation with extensive vascular proliferation was observed by 4 months of age in thalamic, striatal, and cerebellar nuclei associated with somatosensory-motor pathways. At 2 months of age, degenerating mitochondria were observed in most cells in these structures, even in nondegenerating neurons, a finding that indicates mitochondrial injury is a cause rather than an effect of neuronal cell death. Thus, apoptosis-inducing factor deficiency induces early mitochondrial degeneration, followed by progressive multifocal neuropathology (a phenotype broader than previously described), and resembles some histopathologic features of devastating human neurodegenerative mitochondriopathies associated with CI deficiency.
INTRODUCTION
Genetic defects of the mitochondrial respiratory chain components impair oxidative phosphorylation (OXPHOS), a pathomechanism increasingly recognized as an important cause of neurodegeneration (1) . Complex I (NADH:ubiquinoneoxidoreductase, CI) deficiency represents the most common enzyme defect among OXPHOS disorders. Because of the complex structure, function, and regulation of CI, treatment of CI-associated disorders is especially challenging due to the high phenotype variability (2) . In particular, the neurologic features of CI deficiency diseases are associated with a wide range of pathologic changes that may be generalized or restricted to specific regions of the brain. However, some neuropathologic features, such as neuronal loss, focal necrosis and gliosis, are common to most mitochondrial encephalopathies and cerebellar, striatal, and thalamic involvements are frequently observed in these disorders (3) .
The Harlequin (Hq) mouse bears a spontaneous X chromosome-linked murine proviral insertion in the gene encoding the mitochondrial flavoprotein AIF (4), a key component in caspase-independent apoptosis (5Y7). As a consequence, AIF expression is reduced to 20% of normal levels (4) . The recent discovery that AIF deficiency causes CI dysfunction and thereby compromises OXPHOS has conferred a novel function to AIF within mitochondria (8) . Although the molecular mechanisms through which AIF modulates CI assembly and/or stability are unknown, this nonapoptotic function for AIF in sustaining mitochondrial respiration suggests that the Hq mouse may be a promising model for the study of mitochondrial diseases.
Hq mice develop progressive cerebellar ataxia and blindness as primary traits, and localized neurodegeneration has been reported in both the cerebellum and the optic nerve (4), 2 features frequently observed in patients with mitochondrial diseases (9) . However, CI deficiencies often manifest as a more complex and variable multifocal neuropathology. The aim of the present study was to: 1) investigate the neuroanatomical features of Hq mice during the course of the disease, 2) delineate the extent of the neuropathologic changes in the whole brain of Hq mice, and 3) evaluate whether this natural model can be used as a valuable tool to study CI-deficient disorders in vivo.
MATERIALS AND METHODS

Animals
Hq mice were obtained from The Jackson Laboratory (strain B6CBACaA w-J /A-Pdc8
Hq /J) and housed at 21-C and 60% humidity with a 12-hour light/dark cycle and free access to food and water. All experimental protocols were approved by the institutional review committee and met Institut National pour la Santé et la Recherche Médicale (INSERM) guidelines and were carried out in accordance with the Guide for the Care and Use of Laboratory Animals as adopted by the U.S. National Institutes of Health.
Genotyping and Sex Identification
Hemizygous males were obtained by mating heterozygous females and control males. Genomic DNA was purified from tail samples using a MasterPure Kit (Epicentre, Madison, WI). For gender determination, polymerase chain reaction amplification was performed using primers specific to the Sry gene (5 ¶-TGGGACTGGTGA-CAATTGTC-3 ¶ and 5 ¶-GAGTACAGGTGTGCAGCTCT-3 ¶). The affection status (wild-type or mutant) of Aif alleles was determined by multiplex polymerase chain reaction using primers located in the first intron of Aif: 5 ¶-AGTGTC-CAGTCAAAGTACCGG-3 ¶ (forward) and 5 ¶-CTAT-GCCCTTCTCCATGTAGTT-3 ¶ (backward) and in the proviral sequence (5 ¶-CCAGAAACTGTCTCAAGGTTCC-3 ¶ as described previously (4).
Immunohistochemistry
Wild-type and hemizygous males were killed at 2, 4, and 6 months of age by decerebration (n = 5/group). Brains were fixed in formalin and embedded in paraffin. The sagittal plane was selected to observe the caudorostral extension of the brain, including the cerebellum. Sections (10 Km) were mounted on gelatin-coated slides and reacted with anti-glial fibrillary acidic protein (GFAP) (1:500, Z0334; DAKO, Glostrup, Denmark), anti-neuronal nuclei (NeuN) (1:500, MAB377; Chemicon, Temecula, CA), anti-S100A (1:500; Swant, Bellinzona, Switzerland), anti-Iba1 (1:500, 019-19741; Wako, Neuss, Germany), anti-Glut-1 (1:1000, 4670-1601; Biogenesis, Poole, UK), or Fluoro-Jade B (AG310; Chemicon). Detection of primary antibodies was performed with avidin-biotin horseradish peroxidase kits (Vector Laboratories, Burlingame, CA) according to the manufacturer's instructions. Control and experimental groups were processed in parallel in all immunohistochemical procedures.
Western Blot Analysis
Tissue samples were dissected from hemispheres of 5 wild-type and 5 Hq mice, pooled, sonicated in ice-cold lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.5% Nonidet P-40, 0.25% sodium deoxycholate, and protease inhibitors) and centrifuged. Protein concentrations were determined according to the method of Bradford (10) . Lysates were denatured, separated by sodium dodecyl sulfatepolyacrylamide gel electrophoresis, and transferred to polyvinylidene difluoride membranes (Millipore, Billerica, MA). Membranes were probed with anti-AIF (sc-9416; Santa Cruz Biotechnology, Santa Cruz, CA), anti-p30 and 39 kDa FIGURE 1. Expression of apoptosis-inducing factor (AIF), complex I (CI) and astrocytic proteins in ataxic mice (Harlequin [Hq] ) and wild-type littermates (WT). (A) Western blots of cerebellum, cortex, thalamus, and striatum homogenates pooled from four 6-month-old WT and Hq mutant males. Actin was used as a control of equal loading. (B) Semiquantitative analysis of the expression of AIF, oxidative phosphorylation (OXPHOS) CI subunits p39 and p30, glial fibrillary acidic protein (GFAP) and S100A shown in A, expressed as percent relative difference with WT signal intensity. AIF and OXPHOS CI subunits (p39 and p30) were significantly reduced in Hq samples compared with WT samples, whereas GFAP was strongly increased.
(Molecular Probes, Carlsbad, CA), anti-GFAP (CBL411; abcys, Paris, France), anti-S100A (Swant), or anti-Actin (MAB1501; Chemicon) antibodies, and signal was detected by enhanced chemiluminescence.
Electron Microscopy Analysis
Two Hq mutant and wild-type mice at 2, 4, and 6 months of age were perfused transaortically with 20 mL of saline followed by 100 mL of 2% paraformaldehyde with 2% glutaraldehyde at 4-C. Brains were postfixed in 2% paraformaldehyde at 4-C. Sections were cut on a Vibratome at 50 Km thickness and postfixed in 1% glutaraldehyde for 10 minutes, treated with 1% osmium for 10 minutes, and dehydrated in an ascending series of ethanol including 1% uranyl acetate in 70% ethanol. Sections were then treated with propylene oxide, equilibrated overnight in Durcupan ACM (Fluka, Buchs, Switzerland), and flat-embedded on glass slides for 48 hours at 60-C. Areas of interest were cut out and re-embedded in Durcupan blocks, and ultrathin sections were cut on a Reichert ultramicrotome. Ultrathin sections were collected on Formvar-coated, single-slot grids, stained with lead citrate, and examined with a Hitachi H-7600 electron microscope. Mitochondria were counted in the perikarya of granule and Purkinje cells of the cerebellum (lobules VIYIX), and large projection neurons of the thalamus ventral posterolateral (VPL) nucleus and large neurons of the caudate-putamen which are embedded in striatal fiber tracts. A total of 4,513 mitochondria were counted in Hq mice and pathologic changes in mitochondrial ultrastructure (prominent swelling, vacuolization, and disruption of cristal architecture) were recorded.
Quantification of Immunoreactive Cells
Quantitative analysis of immunoreactive cells was performed in the cerebellum (posterior lobules), thalamus (VPL and ventrolateral nuclei), caudate-putamen (dorsomedial area of the striatum) of 2-, 4-, and 6-month-old Hq mutant mice and wild-type littermates. A blinded procedure was used to count labeled cells (original magnification: 400x) in 0.065 mm 2 (0.01625 mm 2 for NeuN in the cerebellum) of 4 sections from at least 4 animals in each group.
Statistical Analysis
All data are reported as means T SEM. The data were evaluated by variance analysis with age (from 2 to 6 months) and group (Hq vs wild-type) as factors. A Bonferroni post-test was used for multiple pairwise comparisons (Prism 4.0; SAS Institute, Chicago, IL).
RESULTS
We studied mice at 2, 4, and 6 months of age, 3 stages that corresponded to mice without ataxia, mice with the first signs of ataxia, and ataxic mice, respectively. The main structures of the telencephalon, the diencephalon, and the mesencephalon were examined. For all of the following data, we report on anatomical regions where significant abnormalities were detected, that is, the cerebellum, the thalamus, the cerebral cortex, and the striatum. 
Reduced Complex I Expression in Apoptosis-Inducing Factor-Deficient Brain Areas from Ataxic Harlequin Mice
After fine dissection of cerebellum, thalamus, cortex, and striatum from 6-month-old animals, the total amount of AIF protein analyzed by Western blot in each tissue was found to be reduced by a factor of 2 to 6 in Hq mice compared with age-matched wild-type littermates (Fig. 1) . In parallel, a strong reduction in the abundance of the respiratory chain p30 and p39 subunits of CI (ranging from 50% to 75%) was detected in all 4 areas analyzed. Thus, AIF-deficient cerebellum, thalamus, cortex, and striatum from ataxic animals all displayed reduced CI expression.
Progressive Astrogliosis in Harlequin Mutant Mice
Astrogliosis often occurs in response to various brain injuries and is frequently encountered in human mitochondriopathies. Therefore, we asked whether it could also occur in Hq mice. Brains at 2, 4, and 6 months of age were used for immunohistochemistry against the GFAP, a major hallmark of the astroglial response. The thalamus of wild-type animals poorly expressed GFAP at all ages observed, whereas that of Hq mutant animals showed an increasing number of GFAPimmunoreactive (IR) astrocytes from 2 to 6 months of age ( Fig. 2A) . Strongly GFAP-IR cells were characterized by a large cell body and processes typical of reactive astroglia. A unique pattern of dense GFAP-IR cells distribution was detected in Hq mice. The ventral thalamic areas including the motor-related nuclei (ventroanterior [VA], ventrolateral [VL] nuclei) and the somatosensory (VPL) nucleus showed strong GFAP staining, spreading progressively throughout the whole thalamus but sparing a small dorsal region even at 6 months ( Fig. 2A) . Examination of the thalamus at medial, intermediate, and lateral sagittal levels indicated that the motor, somatosensory, and visual areas were highly GFAPpositive (Figs. 2B, 3A) , whereas medial (mainly limbic) and dorsal (mainly associative) areas appeared more spared. Consistent with this finding, cell counting in the motorrelated ventrolateral nuclei of the thalamus showed a progressive increase of the number of GFAP-IR cells by a factor of 5 to 10 between 2 and 6 months of age (Fig. 3B) . Similar results were obtained when GFAP-IR cells in the VPL nucleus were counted (not shown). Therefore, progressive astrogliosis in the thalamus of Hq mutant mice selectively affected motor and somatosensory nuclei.
The cerebellum and the striatum also displayed dense GFAP-positive astrogliosis at 2 months, which increased strongly at 4 and 6 months of age. In the cerebellum the astroglial reaction was massive as a high number of enlarged GFAP-IR cell bodies filled the granule cell layer and numerous processes of Bergmann glial cells were GFAP-positive as well (Fig. 4A) . At 4 months of age, the FIGURE 3. Immunohistochemical analysis of the ventrolateral area of the thalamus in Harlequin (Hq) mutant mice and wildtype (WT) littermates at 4 months of age. (A) glial fibrillary acidic protein (GFAP), glucose transporter-1 (Glut-1), Iba1, neuronal nuclei (NeuN), S100A, and Fluoro-Jade B labeling. In the ventrolateral area of the thalamus, GFAP immunostaining was stronger in Hq mutant mice than in wild-type animals. Glut-1 immunostaining revealed a highly developed vascular network and Iba1 immunostaining showed active microglia in the same region. Densities of S100A-positive astrocytes and NeuN-positive neurons were similar in Hq and wild-type animals. Some degenerating neurites were detected with Fluoro-Jade B (white arrows). Scale bar = 50 Km. (B) Quantitative analysis of the number of GFAP-, S100A-and NeuN-immunoreactive cells in the ventrolateral area of the thalamus from Hq and wild-type mice at 2, 4, and 6 months of age. Bars represent the means T SD. Asterisks indicate significant differences between the Hq and the wild-type groups (***, p G 0.001 by 2-way analysis of variance with the Bonferroni correction).
astroglial reaction was visible in the deep nuclei of the cerebellum to an extent similar to that measured in cerebellar lobules (not shown). In the striatum, astrogliosis occurred within and around the fiber tracts and was restricted to its sensorimotor territory, i.e. the caudate-putamen (dorsomedial area) (Fig. 5A) , whereas the limbic territories, which are rather ventral, were not stained. Counting of GFAP-IR cells in the granular layer of cerebellar lobules and the caudate-putamen confirmed that astrogliosis was progressive in both regions (Figs. 4B, 5B) . Moreover, the globus pallidus (which gives rise to the basal ganglia afferents toward the motor thalamus) was also strongly positive for GFAP in 4-month-old Hq mice (not shown).
Astrogliosis was less obvious is the cerebral cortex and varied among animals. Globally, Hq mice displayed more GFAP-IR cells than their wild-type counterparts in the deep cortical layers of the somatosensory cortical areas (not shown).
Because astrogliosis could result from either astrocyte proliferation or increased GFAP expression, S100A protein was used as an alternative marker to assess astrocytic density. Interestingly, S100A staining and counting of S100A-IR cells gave similar results in Hq and wild-type mice in all tissues tested, suggesting that the strong GFAP reactivity resulted from an increased expression of GFAP without astrocytic proliferation (Figs. 3Y5) . Consistent with this finding, semiquantitative measurements of GFAP and S100A expression levels using Western blot on crude protein extracts showed a strong increase of GFAP expression in the cerebellum, thalamus, and striatum of Hq mutant mice compared with wild-type mice, whereas that of S100A showed no difference between the groups (Fig. 1) . Therefore, the astroglial reaction observed in Hq brains is not associated with astrocytes proliferation.
Because astrocytes are known to contribute actively to metabolic support of neurons through nutrient supply (e.g. glucose) and vasomodulation of blood flow, we asked whether the vascular network was changed in the cerebellum, thalamus, cortex, and striatum of Hq mutant mice. Using Glut-1 as a metabolic marker specific for glial cells (11), we found that the microvessels were much thicker, longer, more numerous, and highly splitting in the somatosensory and motor-related thalamic nuclei (but not in limbic areas) of Hq mice compared with wild-type mice (Fig. 3) . This was also obvious in the cerebellum, where both granular and molecular layers displayed an enlarged vascular network (Fig. 4) , and to a lesser extent in the caudate-putamen (Fig. 5 ) and cerebral cortex (not shown). Strong Glut-1-positive staining was also observed in the globus pallidus and in the deep cerebellar nuclei, the same areas where dense astrogliosis had been detected (not shown).
Microglial Reaction in Harlequin Mutant Mice
Microglial cells, the tissue macrophage of the CNS, rapidly activate in response to even minor pathologic changes in the brain, and their activation is among the earliest signs of CNS dysfunction (12, 13) . Distribution of microglia-macrophages was analyzed in Hq mice using Iba1, a macrophage-specific, calcium-binding protein that labels resident and activated microglia (14) . Whereas wild-type animals displayed dispersed labeling of small Iba1-IR resident microglia in the different areas examined at any age, Hq mutant mice presented with clusters of large Iba1-positive activated microglia. As for astroglia, activated microglial cells were numerous in the cerebellar granule cell layer (Fig. 4A) , as well as in fiber tracts of the caudateputamen (Fig. 5A ) and in the somatosensory and motorrelated thalamic nuclei (Fig. 3A) .
Neuronal Cell Death in Harlequin Mutant Mice
As previously reported, Hq mutant mice have progressive degeneration of terminally differentiated cerebellar neurons, with granule cells being affected primarily (4). To visualize neuron loss in cerebellar structures and other brain areas in Hq mice, sections were stained with the selective neuron marker NeuN and with Fluoro-Jade B, a high-affinity fluorescent marker specific for neuronal degeneration during acute neuronal distress. Fluoro-Jade B allows detection of neurons that are undergoing the degenerative process and stains both neurites and cell bodies (15) . At 2 months of age, although the cerebella from wild-type and Hq mice were indistinguishable in size, structure, and neuron number, a restricted number of granule cells were Fluoro-Jade-positive FIGURE 5 . Immunohistochemical analysis of the caudate-putamen in Harlequin (Hq) mutant mice and wild-type (WT) littermates at 4 months of age. (A) Glial fibrillary acidic protein (GFAP), glucose transporter-1 (Glut-1), Iba1, neuronal nuclei (NeuN), S100A, and Fluoro-Jade B labeling. In the thalamocortical fiber tracts, GFAP immunostaining was stronger in Hq mutant mice than in wild-type animals. Glut-1 immunostaining revealed a highly developed vascular network and Iba1 immunostaining showed active microglia in the same region (black arrows). Densities of S100A-positive astrocytes and NeuN-positive neurons appeared similar in Hq and wild-type animals. Fluoro-Jade B detected degenerating neurites specifically located within the fiber tracts (white arrows). Scale bar = 100 Km. (B) Quantitative analysis of the number of GFAP-, S100A-and NeuN-immunoreactive cells in the caudate-putamen from Hq and wild-type mice at 2, 4, and 6 months of age. Bars represent the means T SD. Asterisks indicate significant differences between the Hq group and the wild-type group (**, p G 0.01; ***, p G 0.001, by 2-way analysis of variance with the Bonferroni correction).
in most mutant animals, suggesting that the degenerative process was already ongoing at 2 months (not shown). No neuron loss was detected in other structures at this stage. At 4 months of age, as cerebellar granule cells degenerated massively (Fig. 4A) , numerous Fluoro-Jade B-positive cell bodies and neurites were detected in the deep cerebellar nuclei (Fig. 6) where motor outputs leave the cerebellum toward the thalamus. At the same age, neurite degeneration was detected in the fiber tracts of the caudate-putamen (Fig. 5A) , the globus pallidus (Fig. 6) , and the motor-related thalamic nuclei (Fig. 3A) . However, we did not detect any degenerating cell bodies in these structures after 9 months of age (not shown), and counting of NeuN-IR cells in these areas failed to reveal significant neuronal loss, suggesting that resident neurons were more resistant to AIF/CI deficiency in the basal ganglia and in the thalamus than in the cerebellum. Neurodegenerative cells and processes were also detected in the frontal and parietal cortex as restricted Fluoro-Jade B-positive areas in the deep cortical layers, which matched with the somatosensory and motor cortical regions, respectively (Fig. 6) .
By 6 months of age, more than half of the neurons had died in the granular layer of the cerebellum and Fluoro-Jade B staining was hardly detectable in most mutant mice. However, sustained neurite degeneration was still visible in the deep nuclei, suggesting an ongoing retrograde degenerative process. In the caudate-putamen, neuritic degeneration was more pronounced than at 4 months, whereas it appeared similar in motor-related thalamic nuclei (not shown).
Mitochondria Degeneration in Harlequin Mutant Mice
Consistent with the progressive nature of the Hq phenotype, the decrease of CI levels and activity are progressive (8, 16) , suggesting that not all mitochondria are affected at the same time. Mitochondrial morphology was therefore analyzed in wild-type and Hq mice at 2, 4, and 6 months of age using electron microscopy. Whereas no structural abnormalities of mitochondria were observed in any of the regions studied in wild-type mice, large and swollen mitochondria were observed in most neurons from the cerebellum, somatosensory thalamic nucleus VPL, and caudate-putamen in Hq animals (Fig. 7) . Enlarged mitochondria were degenerated almost completely with partial or total disappearance of the crests. Surprisingly, in both the cerebellum and the thalamus the rate of neurons having at least 1 affected mitochondrion was extremely high, ranging between 70% and 100%, even at 2 months, when no neurodegeneration was detectable except in a few cerebellar granule cells (Table) . In particular, Purkinje cells, which do not die before 7 to 8 months of age, all displayed degenerated mitochondria. Interestingly, the overall rate of degenerating mitochondria in cerebellar granule cells reached 41% at 2 months of age and then shifted to 62% and 82% at 4 and 6 months, respectively, whereas that of Purkinje cells was 3% to 4% at 2 and 4 months and reached only 13% at 6 months. Similar rates of degenerating mitochondria were found in the thalamic somatosensory nucleus VPL (Table) . In the caudateputamen, where no abnormal mitochondrion was detected before 6 months of age, most neurons finally harbored abnormal mitochondria and 23% of mitochondria showed signs of degeneration by 6 months of age. These results demonstrate that the percentage of degenerating mitochondria is well correlated to the neuronal degeneration process in the Hq model and that the degeneration of mitochondria precedes neuronal cell death.
DISCUSSION
The Hq mouse, which has reduced but not abolished AIF expression (4), spontaneously develops a progressive and severe neuronal degeneration associated with mitochondrial CI deficiency (8) . Hence, the aim of the present study was to delineate the neuropathologic features in Hq mutant mice to evaluate whether this natural model is close to human CI-deficient disorders and can thus serve as a tool to study CI-deficient disorders in vivo.
By investigating the whole brain of Hq mice, we have shown that neurodegeneration is not restricted to the cerebellum but progressively affects thalamic, striatal, and cortical regions as well. We found reduced expression of CI subunits in all these brain areas. As shown previously in whole brain extracts, the decreases in CI levels and activity are progressive and tightly correlated (8, 16) . Our finding that most neurons contained at least 1 swollen degenerating mitochondrion, even at 2 months of age in areas where no neuron loss is observed, further suggests that mitochondrial injury precedes the onset of neuronal degeneration. Hence, mitochondrial degeneration is a cause rather than a consequence of the degenerating process, even if we cannot exclude the possibility that this degeneration might enhance mitochondrial injury. Consistent with our findings, mitochondrial dysfunction and oxidative stress occur early in all major FIGURE 6 . Fluoro-Jade B labeling in the somatosensory and motor cortical regions in the globus pallidus and in the deep cerebellar nuclei in Harlequin (Hq) mutant mice at 4 months of age. Degenerating neurons and processes were detected in the deep layers of the motor cortex and the somatosensory cortex from Hq mutant mice at 4 months (arrows). Degenerating neurites were detected in the globus pallidus and in the deep cerebellar nuclei at the same age (arrows). Scale bar = 20 Km.
neurodegenerative diseases. In Alzheimer disease, oxidative damage is the earliest event observed, occurring before the onset of significant plaque pathology (17, 18) . In Cu/Znsuperoxide dismutase mutant mice, a model of amyotrophic lateral sclerosis in which progressive toxicity of the SOD1-G93A mutation poisons motor neurons by impairing mitochondrial energy metabolism (19) , mitochondrial calcium capacity impairment occurs long before the onset of motor symptoms (20) . In Huntington disease as well, mitochondrial calcium abnormalities have been characterized as early events triggered by mutant huntingtin (21) . Moreover, there is now strong evidence that these dysfunctions of mitochondria may have a causal role in the pathogenesis of many neurodegenerative diseases (1) . Thus, in the Hq mutant mice, AIF deficiency in brain induces a typical mitochondrial dysfunction characterized by early mitochondrial degeneration.
Investigating the whole brain of Hq mice using neuronal, glial, and cell death markers, we observed a massive degeneration of cerebellar granule cells, as previously reported (4), but found that it started early, as the degenerative process was already ongoing at 2 months. Interestingly, deep cerebellar neurons, which send motor outputs outside the cerebellum, were also dying at 4 months of age. Degenerating neurites were also detected at the same age within the thalamocortical fibers of the caudate-putamen and in the somatosensory and motor areas of both the thalamus and the cortex. In addition to neuronal cell death the most evident pathologic change was the massive glial reaction that occurred specifically in different areas of the brain, namely the ventrolateral and VPL thalamic nuclei, the cerebellum as a whole, and the caudate-putamen. These regions are functionally involved in the 2 main sensorimotor loops that relay efferent information in the CNS, i.e. the striatothalamocortical pathway and the cerebellothalamocortical pathway. This suggests a specific impairment of the somatosensory-motor capacities in the Hq mouse. Moreover, strong astrogliosis also occurred both in the globus pallidus and in the deep cerebellar nuclei, which serve as intermediates for the relay of motor information between the thalamus and the caudate-putamen or the cerebellum, respectively. Pathologic abnormalities in Hq mice thus affect more brain areas than previously thought and involve both the somatosensory and the motor systems in the CNS. Taken together, these data show that AIF downregulation in the Hq mouse results in a progressive CI deficiency-induced multifocal neuropathology.
Although degenerating neurites were detected by 4 months of age within the fiber tracts of the sensorimotor territory of the basal ganglia and in the somatosensory and motor-related thalamic areas, we did not find any dying cell bodies in these regions up to the age of 9 months. This suggests that, unlike cerebellar granule cells, other neurons are less vulnerable to AIF-induced oxidative stress. Our finding that the number of swollen degenerating mitochondria is much higher in cerebellar granule cells and is well correlated in time with the degeneration process argues in favor of a threshold rate of active mitochondria, below which the degeneration process is triggered. Interestingly, the hypothesis of a threshold level of the neuronal damage has been proposed previously in the pathogenesis of amyotrophic lateral sclerosis, in which progressive toxicity of a SOD1 mutation affects motor neurons (22) . Because both the thalamus and the striatum of Hq mice exhibited a reduction in the abundance of the CI subunits and activity similar to that of the cerebellum, we hypothesize that cerebellar granule cells display a greater susceptibility than other cells to CI deficiency. A number of studies have shown that brain cells differ in their susceptibility to the same oxidative stress insult (23Y25). In particular, a differential regulation of CI activity between glia (upregulation) and neurons (dramatic decrease) has been observed when they are subjected to oxidative stress induced by glutathione depletion (26) . Differences in susceptibility to respiratory chain deficiency might also occur between subtypes of neurons. Alternatively, astrogliosis may differentially influence the neurodegeneration process in the cerebellar granule cells compared with the process in other brain areas. Similar to what we report here for the Hq mice, astrogliosis occurs as one of the earliest pathologic events in the mouse model of amyotrophic lateral sclerosis (27, 28) . A close temporal correlation between the onset of neuronal degeneration and the beginning of astrogliosis has been evidenced in this model, indicating that astrogliosis occurs in response to the initiation of neuronal degeneration and actively participates in the neuronal degeneration process (22) . Although many functions of astrocytes are known, the significance of astrogliosis is still debated (29) . Depending upon the pathophysiologic context it might be either beneficial or detrimental for neuronal survival (30) . In the thalamus and the basal ganglia of Hq mutant mice, the glial reaction starts long before (2 months) the first degenerating neurites can be detected (4 months). The question is therefore raised as to whether gliosis could limit neuronal cell death in these areas, thus avoiding the early onset of degeneration as observed in the cerebellum. Of interest, histopathologic features of Leigh and mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke syndromes, 2 encephalomyelopathies often associated with CI deficiency (31, 32) , involve vascular proliferation, gliosis with relative sparing of neurons in both the basal ganglia (caudate-putamen), and the thalamus, i.e. in the same areas as those involved in Hq mice (3, 33) .
Similar to what we have described for the Hq model, the neurologic features of patients with CI deficiency often include neurodegenerative processes with neuronal loss and gliosis (3) . Multifocal patterns of neuropathology are frequently encountered in these patients; progressive pathologic changes in the cerebellum, the caudate-putamen, and the thalamus have been reported recurrently in overall Affected neurons represent the percentage of affected neurons with at least 1 pathologic mitochondrion in relation to the total number of cells. Degenerated mitochondria represent the percentage of degenerated mitochondria calculated in relation to the total number of mitochondria per cell. VPL, ventroposterolateral nucleus; GC, granule cells; Pkj, Purkinje cells; CPu, caudate-putamen.
clinical pictures of CI-deficient syndromes (34Y41). Analogies between neuropathologic findings in human CI-related disorders and those we described in the Hq mouse make this animal model valuable to investigate neurodegenerative mitochondriopathies associated with CI deficiency in vivo.
